Close

Kemet Reports Preliminary Fiscal 2016 Third Quarter Results

January 28, 2016 8:01 AM EST

GREENVILLE, SC -- (Marketwired) -- 01/28/16 -- KEMET Corporation (the "Company") (NYSE: KEM), a leading global supplier of electronic components, today reported preliminary results for our third fiscal quarter ended December 31, 2015.

Net sales of $177.2 million for the quarter ended December 31, 2015 decreased 4.8% from net sales of $186.1 million for the prior quarter ended September 30, 2015 and decreased 12.0% from net sales of $201.3 million for the quarter ended December 31, 2014. 

The U.S. GAAP net loss was $8.6 million or $0.19 per basic and diluted share for the quarter ended December 31, 2015, which included a non-cash gain of $0.7 million or $0.02 per basic and diluted share related to the change in value of the NEC TOKIN options. This compares to net income of $7.2 million or $0.14 per diluted share for the quarter ended September 30, 2015, which included a non-cash gain of $2.2 million or $0.04 per diluted share related to the change in value of the NEC TOKIN options. For the quarter ended December 31, 2014, the Company reported net income of $2.9 million or $0.06 per diluted share which, for comparison purposes, included a non-cash gain of $2.5 million or $0.05 per diluted share related to the change in value of the NEC TOKIN options.

Non-U.S. GAAP adjusted net income of $2.2 million or $0.04 per diluted share for the quarter ended December 31, 2015 decreased by $2.1 million compared to non-U.S. GAAP adjusted net income of $4.3 million or $0.09 per diluted share in the quarter ended September 30, 2015. For the quarter ended December 31, 2014, the Company reported non-U.S. GAAP adjusted net income of $7.0 million or $0.13 per diluted share.

"Even though the distribution channel continued its inventory correction our OEM and EMS channels remained steady with our adjusted gross margin continuing strong this quarter at 22.2%," stated Per Loof, KEMET's Chief Executive Officer. "We believe the distributor inventory correction is over as bookings are up early this quarter compared to the same time last quarter. Longer term demand will be driven by market innovation by the key customers we serve and we are well positioned to provide creative solutions across multiple end markets with a cost structure that will provide increasing value to our shareholders," continued Loof.

The net income (loss) for the quarters ended December 31, 2015, September 30, 2015 and December 31, 2014 include various items affecting comparability as denoted in the U.S. GAAP to Non-U.S. GAAP reconciliation table included hereafter.

About KEMET

The Company's common stock is listed on the NYSE under the ticker symbol "KEM" (NYSE: KEM). At the Investor Relations section of our web site at http://www.kemet.com/IR, users may subscribe to KEMET news releases and find additional information about our Company. KEMET applies world class service and quality to deliver industry leading, high performance capacitance solutions to its customers around the world and offers the world's most complete line of surface mount and through hole capacitor technologies across tantalum, ceramic, film, aluminum, electrolytic, and paper dielectrics. Additional information about KEMET can be found at http://www.kemet.com.

QUIET PERIOD

Beginning April 1, 2016, we will observe a quiet period during which the information provided in this news release and quarterly report on Form 10-Q will no longer constitute our current expectations. During the quiet period, this information should be considered to be historical, applying prior to the quiet period only and not subject to update by management. The quiet period will extend until the day when our next quarterly earnings release is published.

CAUTIONARY STATEMENT ON FORWARD-LOOKING STATEMENTS

Certain statements included herein contain forward-looking statements within the meaning of federal securities laws about the Company's financial condition and results of operations that are based on management's current expectations, estimates and projections about the markets, in which the Company operates, as well as management's beliefs and assumptions. Words such as "expects," "anticipates," "believes," "estimates," variations of such words and other similar expressions are intended to identify such forward-looking statements. These statements are not guarantees of future performance and involve certain risks, uncertainties and assumptions, which are difficult to predict. Therefore, actual outcomes and results may differ materially from what is expressed or forecasted in, or implied by, such forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which reflect management's judgment only as of the date hereof. The Company undertakes no obligation to update publicly any of these forward-looking statements to reflect new information, future events or otherwise.

Factors that may cause actual outcomes and results to differ materially from those expressed in, or implied by, these forward-looking statements include, but are not necessarily limited to the following: (i) adverse economic conditions could impact our ability to realize operating plans if the demand for our products declines, and such conditions could adversely affect our liquidity and ability to continue to operate; (ii) continued net losses could impact our ability to realize current operating plans and could materially adversely affect our liquidity and our ability to continue to operate; (iii) adverse economic conditions could cause the write down of long-lived assets or goodwill; (iv) an increase in the cost or a decrease in the availability of our principal or single-sourced purchased materials; (v) changes in the competitive environment; (vi) uncertainty of the timing of customer product qualifications in heavily regulated industries; (vii) economic, political, or regulatory changes in the countries in which we operate; (viii) difficulties, delays or unexpected costs in completing the restructuring plans; (ix) equity method investment in NEC TOKIN exposes us to a variety of risks; (x) possible acquisition of NEC TOKIN may not achieve all of the anticipated results; (xi) acquisitions and other strategic transactions expose us to a variety of risks; (xii) our business could be negatively impacted by increased regulatory scrutiny and litigation; (xiii) inability to attract, train and retain effective employees and management; (xiv) inability to develop innovative products to maintain customer relationships and offset potential price erosion in older products; (xv) exposure to claims alleging product defects; (xvi) the impact of laws and regulations that apply to our business, including those relating to environmental matters; (xvii) the impact of international laws relating to trade, export controls and foreign corrupt practices; (xviii) volatility of financial and credit markets affecting our access to capital; (xix) the need to reduce the total costs of our products to remain competitive; (xx) potential limitation on the use of net operating losses to offset possible future taxable income; (xxi) restrictions in our debt agreements that limit our flexibility in operating our business; (xxii) failure of our information technology systems to function properly or our failure to control unauthorized access to our systems may cause business disruptions; (xxiii) additional exercise of the warrant by K Equity which could potentially result in the existence of a significant stockholder who could seek to influence our corporate decisions; and (xxiv) fluctuation in distributor sales could adversely affect our results of operations.

                                                                            
                     KEMET CORPORATION AND SUBSIDIARIES                     
              Condensed Consolidated Statements of Operations               
               (Amounts in thousands, except per share data)                
                                (Unaudited)                                 
                                                                            
                                                 Quarters Ended December 31,
                                                 ---------------------------
                                                     2015          2014     
                                                 ------------- -------------
Net sales                                        $    177,184  $    201,310 
Operating costs and expenses:                                               
  Cost of sales                                       138,436       156,842 
  Selling, general and administrative expenses         22,278        23,374 
  Research and development                              6,134         6,303 
  Restructuring charges                                 1,714         6,063 
  Net (gain) loss on sales and disposals of                                 
   assets                                                 129          (574)
                                                 ------------- -------------
  Total operating costs and expenses                  168,691       192,008 
  Operating income (loss)                               8,493         9,302 
  Non-operating (income) expense:                                           
  Interest income                                          (4)           (5)
  Interest expense                                      9,852         9,938 
  Change in value of NEC TOKIN options                   (700)       (2,500)
  Other (income) expense, net                          (1,320)       (1,201)
                                                 ------------- -------------
  Income (loss) from continuing operations                                  
   before income taxes and equity income (loss)                             
   from NEC TOKIN                                         665         3,070 
  Income tax expense (benefit)                          2,760         1,359 
                                                 ------------- -------------
    Income (loss) from continuing operations                                
     before equity income (loss) from NEC TOKIN        (2,095)        1,711 
  Equity income (loss) from NEC TOKIN                  (6,505)        1,367 
                                                 ------------- -------------
    Income (loss) from continuing operations           (8,600)        3,078 
  Income (loss) from discontinued operations,                               
   net of income tax expense (benefit) of $0 and                            
   $1,976, respectively                                     -          (164)
                                                 ------------- -------------
    Net income (loss)                            $     (8,600) $      2,914 
                                                 ============= =============
Net income (loss) per basic share:                                          
Net income (loss) from continuing operations     $      (0.19) $       0.07 
Net income (loss) from discontinued operations   $          -  $          - 
                                                 ------------- -------------
Net income (loss)                                $      (0.19) $       0.07 
                                                 ============= =============
                                                                            
Net income (loss) per diluted share:                                        
Net income (loss) from continuing operations     $      (0.19) $       0.06 
Net income (loss) from discontinued operations   $          -  $          - 
                                                 ------------- -------------
Net income (loss)                                $      (0.19) $       0.06 
                                                 ============= =============
                                                                            
Weighted-average shares outstanding:                                        
Basic                                                  46,081        45,407 
Diluted                                                46,081        52,228 
                                                                            
                                                                            
                                                                            
                     KEMET CORPORATION AND SUBSIDIARIES                     
                   Condensed Consolidated Balance Sheets                    
               (Amounts in thousands, except per share data)                
                                (Unaudited)                                 
                                                                            
                                                  December 31,   March 31,  
                                                     2015          2015     
                                                 ------------- -------------
ASSETS                                                                      
Current assets:                                                             
  Cash and cash equivalents                      $     43,158  $     56,362 
  Accounts receivable, net                             89,285        90,857 
  Inventories, net                                    175,078       171,843 
  Prepaid expenses and other                           31,051        41,503 
  Deferred income taxes                                 9,734        10,762 
                                                 ------------- -------------
      Total current assets                            348,306       371,327 
  Property, plant and equipment, net of                                     
   accumulated depreciation of $810,373 and                                 
   $804,286 as of December 31, 2015 and March                               
   31, 2015, respectively                             236,347       249,641 
  Goodwill                                             40,294        35,584 
  Intangible assets, net                               33,571        33,282 
  Investment in NEC TOKIN                              35,795        45,016 
  Deferred income taxes                                 4,398         5,111 
  Other assets                                          8,264        12,831 
                                                 ------------- -------------
Total assets                                     $    706,975  $    752,792 
                                                 ============= =============
LIABILITIES AND STOCKHOLDERS' EQUITY                                        
Current liabilities:                                                        
  Current portion of long-term debt              $      5,000  $        962 
  Accounts payable                                     63,665        69,785 
  Accrued expenses                                     44,529        60,456 
  Income taxes payable and deferred income taxes          856         1,017 
                                                 ------------- -------------
      Total current liabilities                       114,050       132,220 
  Long-term debt, less current portion                389,887       390,409 
  Other non-current obligations                        70,921        57,131 
  Deferred income taxes                                 7,707         8,350 
Stockholders' equity:                                                       
  Preferred stock, par value $0.01, authorized                              
   10,000 shares, none issued                               -             - 
  Common stock, par value $0.01, authorized                                 
   175,000 shares, issued 46,508 shares at                                  
   December 31, 2015 and March 31, 2015                   465           465 
  Additional paid-in capital                          452,764       461,191 
  Retained deficit                                   (284,337)     (245,881)
  Accumulated other comprehensive income              (33,687)      (28,796)
  Treasury stock, at cost (648 and 1,056 shares                             
   at December 31, 2015 and March 31, 2015,                                 
   respectively)                                      (10,795)      (22,297)
                                                 ------------- -------------
      Total stockholders' equity                      124,410       164,682 
                                                 ------------- -------------
Total liabilities and stockholders' equity       $    706,975  $    752,792 
                                                 ============= =============
                                                                            
                                                                            
                                                                            
                     KEMET CORPORATION AND SUBSIDIARIES                     
              Condensed Consolidated Statements of Cash Flows               
                           (Amounts in thousands)                           
                                (Unaudited)                                 
                                                                            
                                                   Nine Month Periods Ended 
                                                        December 31,        
                                                 ---------------------------
                                                     2015          2014     
                                                 ------------- -------------
Net income (loss)                                $    (38,456) $      5,704 
Adjustments to reconcile net income (loss) to                               
 net cash provided by (used in) operating                                   
 activities:                                                                
  Gain on sale of discontinued operations                   -        (5,644)
  Net cash provided by (used in) operating                                  
   activities of discontinued operations                    -          (679)
  Depreciation and amortization                        28,856        30,694 
  Equity (income) loss from NEC TOKIN                   4,758            76 
  Non-cash debt and financing costs                       649         1,570 
  (Gain) loss on early extinguishment of debt               -        (1,003)
  Stock-based compensation expense                      3,761         3,185 
  Long-term receivable write down                          24            27 
  Change in value of NEC TOKIN options                 26,300       (13,200)
  Net (gain) loss on sales and disposals of                                 
   assets                                                (233)         (759)
  Pension and other post-retirement benefits              652            87 
  Change in deferred income taxes                         735         1,276 
  Change in operating assets                            4,762          (208)
  Change in operating liabilities                     (32,891)      (24,732)
  Other                                                   526           336 
                                                 ------------- -------------
    Net cash provided by (used in) operating                                
     activities                                          (557)       (3,270)
Investing activities:                                                       
  Capital expenditures                                (14,120)      (17,474)
  Acquisitions, net of cash received                   (2,892)            - 
  Proceeds from sale of assets                            898         4,540 
  Change in restricted cash                                 -        11,509 
  Proceeds from sale of discontinued operations             -         9,564 
                                                 ------------- -------------
    Net cash provided by (used in) investing                                
     activities                                       (16,114)        8,139 
Financing activities:                                                       
  Proceeds from revolving line of credit               10,000        42,340 
  Payments on revolving line of credit                 (5,500)      (14,342)
  Deferred acquisition payments                             -       (11,899)
  Payments on long-term debt                             (481)      (21,733)
  Purchase of treasury stock                             (691)            - 
  Proceeds from exercise of stock options                   -            24 
                                                 ------------- -------------
    Net cash provided by (used in) financing                                
     activities                                         3,328        (5,610)
                                                 ------------- -------------
      Net increase (decrease) in cash and cash                              
       equivalents                                    (13,343)         (741)
Effect of foreign currency fluctuations on cash           139        (1,606)
Cash and cash equivalents at beginning of fiscal                            
 period                                                56,362        57,929 
                                                 ------------- -------------
Cash and cash equivalents at end of fiscal                                  
 period                                          $     43,158  $     55,582 
                                                 ============= =============
                                                                            
                                                                            

Non-U.S. GAAP Financial Measures

The Company utilizes certain Non-U.S. GAAP financial measures, including "Adjusted gross margin", "Adjusted operating income (loss)", "Adjusted net income (loss)", "Adjusted net income (loss) per share" and "Adjusted EBITDA". Management believes that investors may find it useful to review the Company's financial results as adjusted to exclude items as determined by management as further described below.

Adjusted Gross Margin

Adjusted gross margin represents net sales less cost of sales excluding adjustments which are outlined in the quantitative reconciliation provided below. Management uses adjusted gross margin to facilitate our analysis and understanding of our business operations and believes that adjusted gross margin is useful to investors because it provides a supplemental way to understand the underlying operating performance of the Company. Adjusted gross margin should not be considered as an alternative to gross margin or any other performance measure derived in accordance with U.S. GAAP.

The following table provides reconciliation from U.S. GAAP Gross margin to Non-U.S. GAAP adjusted gross margin (amounts in thousands):

                                                                            
                                                Quarters Ended              
                                                  (Unaudited)               
                                   -----------------------------------------
                                    December 31, September 30,  December 31,
                                       2015          2015          2014     
                                   ------------- ------------- -------------
Net sales                          $    177,184  $    186,123  $    201,310 
Cost of sales                           138,436       143,317       156,842 
                                   ------------- ------------- -------------
Gross margin                             38,748        42,806        44,468 
Gross margin as a % of net sales          21.9 %        23.0 %        22.1 %
Non-U.S. GAAP adjustments:                                                  
Plant start-up costs                        160           187         1,144 
Stock-based compensation expense            268           459           424 
Plant shut-down costs                       231             -             - 
Inventory revaluation                         -             -          (927)
                                   ------------- ------------- -------------
  Adjusted gross margin            $     39,407  $     43,452  $     45,109 
                                   ============= ============= =============
Adjusted gross margin as a % of                                             
 net sales                                22.2 %        23.3 %        22.4 %
                                                                            

Adjusted Operating Income (Loss)

Adjusted operating income (loss) represents operating income (loss), excluding adjustments which are outlined in the quantitative reconciliation provided below. We use adjusted operating income (loss) to facilitate our analysis and understanding of our business operations and believe that adjusted operating income (loss) is useful to investors because it provides a supplemental way to understand our underlying operating performance. Adjusted operating loss should not be considered as an alternative to operating income (loss) or any other performance measure derived in accordance with U.S. GAAP.

 Adjusted operating income (loss) is calculated as follows (amounts in thousands):

                                                                            
                                                 Quarters Ended             
                                                  (Unaudited)               
                                    ----------------------------------------
                                    December 31, September 30,  December 31,
                                        2015         2015          2014     
                                    ------------ ------------- -------------
Operating income (loss)             $      8,493 $     13,987  $      9,302 
Adjustments:                                                                
Restructuring charges                      1,714           23         6,063 
Inventory revaluation                          -            -          (927)
Net (gain) loss on sales and                                                
 disposals of assets                         129         (304)         (574)
Stock-based compensation expense           1,154        1,328         1,232 
ERP integration/IT transition costs          167          282           671 
Legal expenses related to antitrust                                         
 class actions                             1,300          541           409 
Plant start-up costs                         160          187         1,144 
Plant shut-down costs                        231            -             - 
NEC TOKIN investment-related                                                
 expenses                                    225          186           485 
                                    ------------ ------------- -------------
Adjusted operating income (loss)    $     13,573 $     16,230  $     17,805 
                                    ============ ============= =============
                                                                            

Adjusted Net Income (Loss) and Adjusted Net Income (Loss) Per Share

"Adjusted net income (loss)" and "Adjusted net income (loss) per basic and diluted share" represent net income (loss) and net income (loss) per basic and diluted share excluding adjustments which are outlined in the quantitative reconciliation provided below. Management believes that these Non-U.S. GAAP financial measures are useful to investors because they provide a supplemental way to understand the underlying operating performance of the Company. Management uses these Non-U.S. GAAP financial measures to evaluate operating performance. Non-U.S. GAAP financial measures should not be considered as an alternative to net income, operating income or any other performance measures derived in accordance with U.S. GAAP.

The following table provides reconciliation from U.S. GAAP net income (loss) to Non-U.S. GAAP Adjusted net income (loss) (amounts in thousands):

                                                                            
     U.S. GAAP to Non-U.S. GAAP                                             
           Reconciliation                        Quarters Ended             
                                     ---------------------------------------
                                      December 31,  September   December 31,
                                         2015       30, 2015       2014     
                                     ------------- ----------- -------------
U.S. GAAP                                                        (Unaudited)
Net sales                            $    177,184  $  186,123  $    201,310 
Net income (loss) from continuing                                           
 operations                                (8,600)      7,194         3,078 
    Income (loss) from discontinued                                         
     operations                                 -           -          (164)
                                     ------------- ----------- -------------
Net income (loss)                    $     (8,600) $    7,194  $      2,914 
                                     ============= =========== =============
Earnings per basic and diluted                                              
 share:                                                                     
Net income (loss) from continuing                                           
 operations                                 (0.19)       0.16          0.07 
Income (loss) from discontinued                                             
 operations                                     -           -             - 
                                     ------------- ----------- -------------
Net income (loss)                           (0.19)       0.16          0.07 
                                     ============= =========== =============
Net income (loss) from continuing                                           
 operations - diluted                       (0.19)       0.14          0.06 
Income (loss) from discontinued                                             
 operations - diluted                           -           -             - 
                                     ------------- ----------- -------------
Net income (loss) - diluted                 (0.19)       0.14          0.06 
                                     ============= =========== =============
  Non-U.S. GAAP                                                             
    Net income (loss)                $     (8,600) $    7,194  $      2,914 
    Adjustments:                                                            
      Restructuring charges                 1,714          23         6,063 
      Equity (income) loss from NEC                                         
       TOKIN                                6,505        (162)       (1,367)
      Inventory revaluation                     -           -          (927)
      Net (gain) loss on sales and                                          
       disposals of assets                    129        (304)         (574)
      (Gain) loss on early                                                  
       extinguishment of debt                   -           -        (1,003)
      Offering Memorandum Fees                  -           -         1,142 
      Stock-based compensation                                              
       expense                              1,154       1,328         1,232 
      Legal expenses related to                                             
       antitrust class actions              1,300         541           409 
      ERP integration/IT transition                                         
       costs                                  167         282           671 
      Change in value of NEC TOKIN                                          
       options                               (700)     (2,200)       (2,500)
      Plant start-up costs                    160         187         1,144 
      Plant shut-down costs                   231           -             - 
      Net foreign exchange (gain)                                           
       loss                                (1,036)     (3,171)       (1,257)
      NEC TOKIN investment-related                                          
       expenses                               225         186           485 
      (Income) loss from                                                    
       discontinued operations                  -           -           164 
      Amortization included in                                              
       interest expense                       212         217           322 
      Income tax effect of pension                                          
       curtailment                            720           -             - 
      Income tax effect of non-GAAP                                         
       adjustments (1)                        (10)        153            37 
                                     ------------- ----------- -------------
Adjusted net income (loss)           $      2,171  $    4,274  $      6,955 
                                     ============= =========== =============
Adjusted net income (loss) per basic                                        
 share                               $       0.05  $     0.09  $       0.15 
Adjusted net income (loss) per                                              
 diluted share                       $       0.04  $     0.09  $       0.13 
Weighted Average Shares-Basic              46,081      45,767        45,407 
Weighted Average Shares-Diluted            51,865      50,004        52,228 
                                                                            

(1) The income tax effect of the excluded items is calculated by applying the applicable jurisdictional income tax rate, considering the deferred tax valuation for each applicable jurisdiction.

Adjusted EBITDA

Adjusted EBITDA represents net income (loss) before net interest expense, income tax expense (benefit), and depreciation and amortization expense, adjusted to exclude certain items which are outlined in the quantitative reconciliation provided herein. We use adjusted EBITDA to monitor and evaluate our operating performance and to facilitate internal and external comparisons of the historical operating performance of our business. We present adjusted EBITDA as a supplemental measure of our performance and ability to service debt. We also present adjusted EBITDA because we believe such measure is frequently used by securities analysts, investors and other interested parties in the evaluation of companies in our industry.

We believe adjusted EBITDA is an appropriate supplemental measure of debt service capacity, because cash expenditures on interest are, by definition, available to pay interest, and tax expense is inversely correlated to interest expense because tax expense goes down as deductible interest expense goes up; depreciation and amortization are non-cash charges. The other adjustments to arrive at adjusted EBITDA are excluded in order to better reflect our continuing operations.

In evaluating adjusted EBITDA, you should be aware that in the future we may incur expenses similar to the adjustments noted below. Our presentation of adjusted EBITDA should not be construed as an inference that our future results will be unaffected by these types of adjustments. Adjusted EBITDA is not a measurement of our financial performance under U.S. GAAP and should not be considered as an alternative to net income, operating income or any other performance measures derived in accordance with U.S. GAAP or as an alternative to cash flow from operating activities as a measure of our liquidity.

Our adjusted EBITDA measure has limitations as an analytical tool, and should not be considered in isolation or as a substitute for analysis of our results as reported under U.S. GAAP. Some of these limitations are:

  • it does not reflect our cash expenditures, future requirements for capital expenditures or contractual commitments;
  • it does not reflect changes in, or cash requirements for, our working capital needs;
  • it does not reflect the significant interest expense or the cash requirements necessary to service interest or principal payment on our debt;
  • although depreciation and amortization are non-cash charges, the assets being depreciated and amortized will often have to be replaced in the future, and our adjusted EBITDA measure does not reflect any cash requirements for such replacements;
  • it is not adjusted for all non-cash income or expense items that are reflected in our statements of cash flows;
  • it does not reflect the impact of earnings or charges resulting from matters we consider not to be indicative of our ongoing operations;
  • it does not reflect limitations on or costs related to transferring earnings from our subsidiaries to us; and
  • other companies in our industry may calculate this measure differently than we do, limiting its usefulness as a comparative measure.

Because of these limitations, adjusted EBITDA should not be considered as a measure of discretionary cash available to us to invest in the growth of our business or as a measure of cash that will be available to us to meet our obligations. You should compensate for these limitations by relying primarily on our U.S. GAAP results and using adjusted EBITDA as supplementary information.

 The following table provides a reconciliation from U.S. GAAP net income (loss) to Adjusted EBITDA (amounts in thousands):

                                                                            
                                            For the Quarters Ended          
                                                  (Unaudited)               
                                   -----------------------------------------
                                    December 31, September 30,  December 31,
                                       2015          2015          2014     
                                   ------------- ------------- -------------
Net income (loss)                  $     (8,600) $      7,194  $      2,914 
Interest expense, net                     9,848         9,808         9,933 
Income tax expense (benefit)              2,760         1,438         1,359 
Depreciation and amortization             9,674         9,265         9,720 
                                   ------------- ------------- -------------
  EBITDA                                 13,682        27,705        23,926 
Excluding the following items:                                              
Restructuring charges                     1,714            23         6,063 
Legal expenses related to                                                   
 antitrust class actions                  1,300           541           409 
Equity (income) loss from NEC                                               
 TOKIN                                    6,505          (162)       (1,367)
Inventory revaluation                         -             -          (927)
Net (gain) loss on sales and                                                
 disposals of assets                        129          (304)         (574)
(Gain) loss on early                                                        
 extinguishment of debt                       -             -        (1,003)
Offering Memorandum Fees                      -             -         1,142 
Stock-based compensation expense          1,154         1,328         1,232 
ERP integration/IT transition                                               
 costs                                      167           282           671 
Change in value of NEC TOKIN                                                
 options                                   (700)       (2,200)       (2,500)
Plant start-up costs                        160           187         1,144 
Plant shut-down costs                       231             -             - 
Net foreign exchange (gain) loss         (1,036)       (3,171)       (1,257)
NEC TOKIN investment-related                                                
 expenses                                   225           186           485 
(Income) loss from discontinued                                             
 operations                                   -             -           164 
                                   ------------- ------------- -------------
  Adjusted EBITDA                  $     23,531  $     24,415  $     27,608 
                                   ============= ============= =============
                                                                            
   Contact:
 
William M. Lowe, Jr. Executive Vice President and
 Chief Financial Officer
 [email protected]
 
 864-963-6484
 Richard J. VatinelleVice President and Treasurer [email protected]

Source: KEMET Corporation



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Press Releases

Related Entities

Earnings, Definitive Agreement